Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: Summary findings from the Casa Pia Children's Amalgam Clinical Trial

NeuroToxicology

Volumn 44, Issue , 2014, Pages 288-302

  Woods, James S ^a   Heyer, Nicholas J ^b   Russo, Joan E ^c   Martin, Michael D ^a   Farin, Federico M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Genetic susceptibility; Mercury; Neurobehavioral function; Neurotoxicity

Indexed keywords

APOLIPOPROTEIN E; CATECHOL METHYLTRANSFERASE; GLUTATHIONE TRANSFERASE T1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; SEROTONIN TRANSPORTER;

ALLELE; APOE GENE; ARTICLE; CHILD; CHILD HEALTH; COMT GENE; CPOX GENE; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRIN2A GENE; GRIN2B GENE; GSTT1 GENE; HUMAN; INDEL MUTATION; KIBRA GENE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MERCURIALISM; MT1M GENE; MT2A GENE; NEUROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPP1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A4 GENE; TDO2 GENE; URINE LEVEL; CHEMICALLY INDUCED; CLINICAL TRIAL (TOPIC); DISEASE PREDISPOSITION; GENETICS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

CHILD; CLINICAL TRIALS AS TOPIC; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MERCURY POISONING, NERVOUS SYSTEM; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC;

EID: 84907346796     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.07.010     Document Type: Article

References (76)

1. Adams J., Crosbie J., Wigg K., Ickowicz A., Pathare T., Roberts W., et al. Glutamate receptor, ionotropic, N-methyl d-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry 2004, 9:494-499.
2. Arbelle S., Benjamin J., Golin M., Kremer I., Belmaker R.H., Ebstein R.P. Relation of shyness in grade school children for the long form of the serotonin transporter promoter region polymorphism. Amer J Psychiatry 2003, 160:671-676.
3. Aschner M., Syversen T., Souza D.O., Rocha J.B.T. Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Exp Biol Med 2006, 231:1468-1473.
4. Baccarelli A., Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009, 21:243-251.
5. Baraldi M., Zanoli P., Tascedda F., Blom J.M.C., Brunello N. Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure. Environ Health Perspect 2002, 110:855-858.
6. Barnett J.H., Heron J., Goldman D., Jones P.B., Xu K. Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatry 2009, 16:909-916.
7. Basu N., Goodrich J.M., Head J. Ecogenetics of mercury: from genetic polymorphisms and epigenetics to risk assessment and decision making. Environ Toxicol Chem 2013, 10.1002/etc.2375.
8. Bellinger D.C., Trachtenberg F., Barregard L., Tavares M., Chernichiari E., Daniel D., et al. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 2006, 295:1775-1783.
9. Burkhalter J., Fiumelli H., Allaman I., Chatton J.-Y., Martin J.L. Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J Neurosci 2003, 23:8212-8220.
10. Buttini M., Orth M., Bessosta S., Akeefe H., Pitas R.E., Wyss-Coray T. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci 1999, 19:4867-4880.
11. Capsi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
12. Castoldi A.F., Onishchenko N., Johansson C., Coccini T., Roda E., Vahter M., et al. Neurodevelopmental toxicity of methylmercury: laboratory animal data and their contribution to human risk assessment. Regul Toxicol Pharmacol 2008, 51:215-229.
13. Centers for Disease Control and Prevention National Health and Nutrition Examination Survey 2007, Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 24.07.14].
14. Chernova T., Nicotera P., Smith A.G. Heme deficiency is associated with senescence and causes suppression of N-methyl-d-aspartate receptor subunits expression in primary cortical neurons. Mol Pharmacol 2006, 69:697-705.
15. Clarkson T.W. The three faces of mercury. Environ Health Perspect 2002, 110(Suppl. 1):11-23.
16. Comings D.E., Gade R., Muhleman D., Chiu C., Wu S., To M., et al. Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse, and other disorders. Pharmacogenetics 1996, 6:407-418.
17. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996, 1:434-436.
18. DeRouen T.A., Leroux B.G., Martin M.D., Townes B.D., Woods J.S., Leitão J., et al. Issues in the design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children. Control Clin Trials 2002, 23:301-320.
19. DeRouen T.A., Martin M.D., Leroux B.G., Townes B.D., Woods J.S., Leitão J., et al. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA 2006, 295:1784-1792.
20. Echeverria D., Heyer N.J., Martin M.D., Naleway C.A., Woods J.S., Bittner A.C. Behavioral effects of low-level exposure to Hg0 among dentists. Neurotoxicol Teratol 1995, 17:161-168.
21. Echeverria D., Woods J.S., Heyer N.J., Martin M.D., Rohlman D.S., Farin F.M., et al. The association between serotonin transporter gene promoter polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans. J Toxicol Environ Health A 2010, 73:1003L 1020.
22. Echeverria D., Woods J.S., Heyer N.J., Rohlman D.S., Farin F.M., Bittner A.C., et al. Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor functions. Neruotoxicol Teratol 2005, 27:781-796.
23. Echeverria D., Woods J.S., Heyer N.J., Martin M.D., Rohlman D.S., Farin F.M., et al. The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol Teratol 2006, 28:39-48.
24. Eddins D., Petro A., Pollard N., Freedman J.H., Levin E.D. Mercury-induced cognitive impairment in metallithionein-1/2 null mice. Neurotoxicol Teratol 2008, 30:88-95.
25. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of DBDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
26. Endele S., Rosenberger G., Geider K., Popp B., Tamer C., Stefanova I., et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 2010, 42:1021-1026.
27. Fleming J.L., Huang T.H., Toland A.E. The role of parental and grandparental epigenetic alterations in familial cancer risk. Cancer Res 2008, 68:9116-9121.
28. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
29. Goodrich J.M., Basu N., Franzblau A., Dolinoy D.C. Mercury biomarkers and DNA methylation among Michigan dental professionals. Environ Mol Mutagen 2013, 54:195-203.
30. Goodrich J.M., Wang Y., Gillespie B., Werner R., Franzblau A., Basu N. Glutathione enzyme and selenoprotein polymorphisms associate with mercury biomarker levels in Michigan dental professionals. Toxicol Appl Pharmacol 2011, 257:301-308.
31. Grandjean P., Weihe P., White R.F., Debes F., Araki S., Yokoyama K., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997, 19:417-428.
32. Gundacker C., Komarnicki G., Jagiello P., Gencikova A., Dahman N., Wittmann K.J., et al. Glutathione-S-transferase polymorphism, metallothionein expression, and mercury levels among students in Austria. Sci Total Environ 2007, 385:37-47.
33. Gundacker C., Wittmann K.J., Kukuckova G., Hikkel I., Gencik M. Genetic background of lead and mercury metabolism in a group of medical studies in Austria. Environ Res 2009, 109:786-796.
34. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33:3037-3045.
35. Heyer N.J., Echeverria D., Bittner A.C., Farin F.M., Garabedian C.C., Woods J.S. Chronic low-level mercury exposure BDNF polymorphism, and associations with self-reported symptoms and mood. Toxicol Sci 2004, 81:354-363.
36. Heyer N.J., Echeverria D., Farin F.M., Woods J.S. The association between serotonin transporter gene promotor polymorphism (5-HTTLPR), self-reported symptoms, and dental mercury exposure. J Toxicol Environ Health A 2008, 71:1381-1386.
37. Heyer N.J., Echeverria D., Martin M.D., Farin F.M., Woods J.S. Catechol O-methyltransferase (COMT) VAL158MET functional polymorphism, dental mercury exposure and self-reported symptoms and mood. J Toxicol Environ Health A 2009, 72:599-609.
38. Hultman P., Nielsen J.B. The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity. J Autoimmunol 2001, 17:27-37.
39. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8:253-262.
40. Kanai M., Funakoshi H., Takahashi H., Hayakawa T., Mizuno S., Matsumoto K., et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2009, 2:8.
41. Krieg E.F., Chrislip D.W., Letz R.E., Otto D.A., Crespo C.J., Brightwell W.S., et al. Neurobehavioral test performance in the third National Health and Nutrition Examination Survey. Neurotoxicol Teratol 2001, 23:569-589.
42. Landrigan P.J., Goldman L.R. Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff 2011, 30:842-850.
43. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related behavior traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
44. Li T., Woods J.S. Cloning, expression, and biochemical properties of CPOX4, a genetic variant of coproporphyrinogen oxidase that affects susceptibility to mercury toxicity in humans. Toxicol Sci 2009, 109:228-236.
45. Litman D.A., Correia M.A. l-Tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria?. Science 1983, 222:1031-1033.
46. Liu Y., Rutlin M., Huang S., Barrick C.A., Wang F., Jones K.R., et al. Sexually dimorphic BDNF signaling directs sensory innervation of the mammary gland. Science 2012, 338:1357-1360.
47. Martins I.P., Castro-Caldas A., Townes B.D., Ferreira G., Rodrigues P., Marques S., et al. Age and sex differences in neurobehavioral performance: a study of Portuguese elementary school children. Int J Neurosci 2005, 115:1687-1709.
48. McCarthy M.M., Auger A.P., Bale T.L., De Vries G.T., Dunn G.A., Forger N.G., et al. The epigenetics of sex differences in the brain. J Neurosci 2009, 29:12815-12823.
49. Myers G.J., Marsh D.O., Davidson P.W., Cox C., Shamlaye C.F., Tanner M., et al. Main neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from a maternal fish diet: outcome at 6 months. Neurotoxicology 1995, 16:677-688.
50. Nabi R., Serajee F.J., Chugani D.C., Zhory H., Huq A.H. Association of tryptophan 2,3-dioxygenase gene polymorphism with autism. Amer J Med Genet 2004, 125B:63-68.
51. Nackley A.G., Shabalina S.A., Lambert J.E., Conrad M.S., Gibson D.G., Spiridonov A.N., et al. Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: evidence for marker SNPs. PLOS ONE 2009, 4:e5237.
52. Nakayama A., Hill K.E., Motley A.K., Burk R.F. All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium. J Nutr 2007, 137:690-693.
53. Ng S., Lin C.-C., Hwang Y.-H., Hsieh W.-S., Liao H-F., Chen P.-C. Mercury APOE, and children's neurodevelopment. Neurotoxicology 2013, 37:85-92.
54. Papassotiropoulos A., Stephan D.A., Huentelman M.J., Hoerndli F.J., Craig D.W., Pearson J.V., et al. Common KIBRA alleles are associated with human memory performance. Science 2006, 314:475-478.
55. Pieper I., Wehe C.A., Bornhorst J., Ebert F., Leffers L., Holtkamp M., et al. Mechanisms of Hg species induced toxicity in cultured human astrocytes: genotoxicity and DNA-damage response. Metallomics 2014, 6:662-671.
56. Pingree S.D., Simmonds P.L., Woods J.S. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats. Toxicol Sci 2001, 61:224-233.
57. Ren S., Correia M.A. Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase?. Arch Biochem Biophys 2000, 377:195-203.
58. Schadt E.E., Zhang B., Zhu J. Advances in systems biology and enhancing our understanding of disease and moving us closer to novel disease treatments. Genetica 2009, 136:2259-2269.
59. Schaper K., Kolsch H., Popp J., Wagner M., Jennen F. KIBRA gene variants are associated with episodic memory in healthy elderly. Neurobiol Aging 2008, 29:1123-1125.
60. Schläwiche Engström K.S., Stromberg U., Lundh T., Jonhansson I., Vessby B., Hallmans G., et al. Genetic variation in glutathione-related genes and body burden of methylmercury. Environ Health Perspect 2008, 116:734-739.
61. Sherman L.S., Blum J.D., Franzblau A., Basu N. New insights into biomarkers of human mercury exposure using naturally occurring mercury isotopes. Environ Sci Technol 2013, 47:3403-3409.
62. Smith A.G., Raven E.L., Chernova T. The regulatory role of heme in neurons. Metallomics 2012, 3:955-962.
63. Spulber S., Rantamäki T., Nikkilä O., Castrén E., Weihe P., Grandjean P., et al. Effects of maternal smoking and exposure to methylmercury on brain-derived neurotrophic factor concentrations in umbilical cord serum. Toxicol Sci 2010, 117:263-269.
64. Townes B.D., Martins I.P., Castro-Caldas A., Rosenbaum G., DeRouen T. Repeat test scores on neurobehavioral measures over an eight-year period in a sample of Portuguese children. Int J Neurosci 2008, 118:79-93.
65. Townes B.D., Rosenbaum J.G., Martins I.P., Castro-Caldas A. Neurobehavioral assessment in children: a cross-cultural perspective. Psychologica 2003, 34:817-820.
66. Tsai C.L., Jang T.H., Wang L.H. Effects of mercury on serotonin concentrations in the brain of tilapia, Orreochromis mossambicus. Neurosci Lett 1995, 184:208-211.
67. Wang Y., Goodrich J.M., Gillespie B., Basu N., Franzblau A. An investigation of modifying effects of metallothionein single-nucleotide polymorphisms on the association between mercury exposure and biomarker levels. Environ Health Perspect 2012, 120:530-534.
68. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyl ransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999, 39:19-52.
69. West A.K., Hidalgo J., Eddins D., Levin L.D., Aschner M. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 2008, 29:489-503.
70. Woods J.S., Echeverria D., Heyer N.J., Simmonds P.L., Wilkerson J., Farin F.M. The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol Appl Pharmacol 2005, 206:113-120.
71. Woods J.S., Heyer N.J., Echeverria D., Russo J.E., Martin M.D., Bernardo M.F., et al. Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children. Neurotoxicol Teratol 2012, 34:513-521. PMID: 22765978.
72. Woods J.S., Heyer N.J., Russo J.E., Martin M.D., Pillai P.B., Farin F.M. Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children. Neurotoxicol Teratol 2013, 39:36-44. PMID: 23827881.
73. Woods J.S., Heyer N.J., Russo J.E., Martin M.D., Pillai P.B., Bammler T.K., et al. Genetic polymorphisms of catechol-O-methyltransferase modify the neurobehavioral effects of mercury in children. J Toxicol Environ Health A 2014, 77:293-312.
74. Woods J.S., Martin M.D., Leroux B.G., DeRouen T.A., Leitão J.G., Bernardo M., et al. The contribution of dental amalgam to urinary mercury excretion in children. Environ Health Perspect 2007, 115:527-1531. PMID: 17938746.
75. Wright R.O., Hu H., Silverman E.K., Tsaih S.W., Schwartz J., Dellinger D., et al. Apolipoprotein E genotype predicts 24-month Bayley Scales Infant Development score. Pediatr Res 2003, 54:819-825.
76. Xie T., Ho S.L., Ramsden D.B. Characterization and implications of estrogenic down-regulation of human catechol-O-methyl transferase gene transcription. Mol Pharmacol 1999, 56:3-38.